Importantly, ChIP assays revealed significantly increased binding of PRDM1 to the SLC30A9 promoter region in cervical cancer tissues, providing strong evidence for PRDM1’s direct involvement in upregulating SLC30A9 expression. This evidence concerns the gene PRDM1 and cervical cancer.